BOSTON SCIENTIFIC CORP — Director's Dealing 2021

Dec 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-12-20

Reporting Person: Pierce David A (EVP Pres MedSurg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-20	Common Stock	M	42934.0000	$7.3900	Acquired	44991.0000	Direct
2021-12-20	Common Stock	M	4997.0000	$6.2800	Acquired	49988.0000	Direct
2021-12-20	Common Stock	S	49988.0000	$39.9020	Disposed	0.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-20	Stock Option (Right to Buy)	$6.2800	M	4997.0000	Disposed	2022-02-27	Common Stock (4997.0000)	Direct
2021-12-20	Stock Option (Right to Buy)	$7.3900	M	42934.0000	Disposed	2023-02-28	Common Stock (42934.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.47 to $40.31, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.